Cargando…

Endotoxin removal by polymyxin B: is it a question of dose or duration or both?

Detalles Bibliográficos
Autores principales:	Honore, Patrick M., De Bels, David, Barreto Gutierrez, Leonel, Redant, Sebastien, Gallerani, Andrea, Boer, Willem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724261/ https://www.ncbi.nlm.nih.gov/pubmed/31484574 http://dx.doi.org/10.1186/s13054-019-2584-5

Ejemplares similares

Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
por: Honore, Patrick M., et al.
Publicado: (2019)

Icatibant, another piece of the therapeutic puzzle regarding hemodynamic side effects of angiotensin-converting enzyme inhibitors
por: Honore, Patrick M., et al.
Publicado: (2019)

Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue?
por: Honore, Patrick M., et al.
Publicado: (2019)

Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
por: Honore, Patrick M., et al.
Publicado: (2018)

Is cortical perfusion a reliable marker for predicting septic acute kidney injury?
por: Honore, Patrick M., et al.
Publicado: (2019)

Hepcidin is described as the master regulator of iron: could its removal by CRRT lead to iron dysmetabolism in the critically ill?
por: Honore, Patrick M., et al.
Publicado: (2020)

TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2020)

High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
por: Honore, Patrick M., et al.
Publicado: (2020)

Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
por: Honore, Patrick M., et al.
Publicado: (2018)

Success rate of naso-jejunal tube placement influenced by CRRT: possible removal of metoclopramide
por: Honore, Patrick M., et al.
Publicado: (2021)

How levosimendan can improve renal function?
por: Honore, Patrick M., et al.
Publicado: (2019)

Obesity inducing acute respiratory distress syndrome: we should choose the right population!
por: Honore, Patrick M., et al.
Publicado: (2019)

What should be the best dialysis catheter lock in critically ill patients?
por: Honore, Patrick M., et al.
Publicado: (2019)

Study conclude that TXA in severely injured was associated with lower mortality: beware of potential confounders
por: Honore, Patrick M., et al.
Publicado: (2021)

Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
por: Honore, Patrick M., et al.
Publicado: (2022)

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider
por: Honore, Patrick M., et al.
Publicado: (2020)

Mortality in non-elderly septic patients was increased with hypothermia and decreased with fever while mortality in elderly patients was not associated with body temperature: beware of some confounders!
por: Honore, Patrick M., et al.
Publicado: (2020)

A retrospective study in adult patients with septic shock and multiple organ failure demonstrated improved 28-day survival with adjunct TPE compared to standard care alone: true effect or mediated by a negative fluid balance achieved by RRT?
por: Honore, Patrick M., et al.
Publicado: (2020)

Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
por: Honore, Patrick M., et al.
Publicado: (2020)

Inhibiting IL-6 in COVID-19: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Irrespective of the degree of hyperlactatemia, similar lactate levels were associated with a lower mortality rate in metformin users compared with non-users: beware of confounders!
por: Honore, Patrick M., et al.
Publicado: (2020)

SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy
por: Honore, Patrick M., et al.
Publicado: (2020)

Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Using indirect calorimetry in place of fixed energy prescription was feasible and energy targets were more closely met: do not forget an important limitation
por: Honore, Patrick M., et al.
Publicado: (2020)

Early latency evoked potentials can no longer be considered an infallible predictor of neurologic outcome
por: Honore, Patrick M., et al.
Publicado: (2020)

Liver injury without liver failure in COVID-19 patients: how to explain, in some cases, elevated ammonia without hepatic decompensation
por: Honore, Patrick M., et al.
Publicado: (2020)

Detecting influenza-associated pulmonary aspergillosis by determination of galactomannan in broncho-alveolar lavage fluid and in serum: should we add (1,3)-beta-D-glucan to improve efficacy
por: Honore, Patrick M., et al.
Publicado: (2020)

Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2020)

Patients with emm1/T1 serotype invasive group A streptococci infections demonstrated more renal failure than patients with other serotypes: perhaps we should consider some confounders
por: Honore, Patrick M., et al.
Publicado: (2020)

Risk of harlequin syndrome during bi-femoral peripheral VA-ECMO: should we pay more attention to the watershed or try to change the venous cannulation site?
por: Honore, Patrick M., et al.
Publicado: (2020)

Interleukin-26 is a promising biomarker of sepsis but is it always reliable?
por: Honore, Patrick M., et al.
Publicado: (2019)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
por: Honore, Patrick M., et al.
Publicado: (2019)

Dysbiosis of the microbiota in neurocritically ill patients associated with coma and death: ammonia as a potential missing link
por: Honore, Patrick M., et al.
Publicado: (2019)

Biomarker suPAR seems a good prognostic factor for community-acquired pneumonia but less prominent for septic shock
por: Honore, Patrick M., et al.
Publicado: (2019)

High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!
por: Honore, Patrick M., et al.
Publicado: (2021)

A Study Revealed That a High Percentage of Patients With Severe COVID-19 With Viral RNAaemia Had Significantly Worse Outcomes, and This Is the First Report About the Risk Factors of Viral RNAaemia in Patients With COVID-19: We Are Not Sure!
por: Honore, Patrick M., et al.
Publicado: (2021)

Spontaneous Pneumothorax (SP) in COVID-19 Is Associated With Worse Outcomes Than SP in Non-COVID-19 Patients, Which Suggests That SP in COVID-19 is a Sign of Disease Severity: Is This Finding a Pure Association or Is There Really a Strong Relationship Between the Two?
por: Honore, Patrick M., et al.
Publicado: (2021)

Are SOFA score, PaO(2)/FiO(2) ratio, lymphocytes levels, total bilirubin, lactate dehydrogenase, ferritin, C-reactive protein and interleukin-6 significantly normalized following TPE completion: Is this fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2021)

In severe liver disease, citrate can be used safely: the question remains—by which mechanism
por: Honore, Patrick M., et al.
Publicado: (2020)

Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
por: Honore, Patrick M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_if6npdode4qpc7lhmmh0i6mbav